Three-month follow-up of shoulder-hand syndrome induced by phenobarbital and treated with gabapentin.
In the present study we evaluated the 3-month follow-up of 14 subjects with phenobarbital-induced shoulder-hand syndrome after discontinuation of their previous pharmacological treatment (group 1: gabapentin 100 mg/day; group 2: acetaminophen 3 g/day for 3 months). The aim of this study was to evaluate pain and joint function in each group after cessation of treatment and to compare the results in the two groups. The result for pain and joint function was better in the seven patients previously treated with gabapentin.
Rovetta
G
G
DISEM, University of Genova, Rheumatology Center, Bruzzone Institute, Italy.
Baratto
L
L
Farinelli
G
G
Monteforte
P
P
D000082:Acetaminophen / Q000627:therapeutic use*; D000085:Acetates / Q000627:therapeutic use*; D000588:Amines; D000700:Analgesics / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000009:adverse effects*; D018771:Arthralgia / Q000188:drug therapy / Q000503:physiopathology; D003509:Cyclohexanecarboxylic Acids; D005260:Female; D005500:Follow-Up Studies; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008662:Metacarpophalangeal Joint / Q000503:physiopathology; D008875:Middle Aged; D009437:Neuralgia / Q000188:drug therapy / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy; D010634:Phenobarbital / Q000009:adverse effects*; D012019:Reflex Sympathetic Dystrophy / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D020069:Shoulder Pain / Q000188:drug therapy / Q000503:physiopathology; D016896:Treatment Outcome; D014459:Ulnar Nerve / Q000503:physiopathology; D014955:Wrist Joint / Q000503:physiopathology; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000700:Analgesics; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D000082:Acetaminophen; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D010634:Phenobarbital